UroGen Pharma Ltd

NASDAQ:URGN 4:00:00 PM EDT

18.07

+0.01 (+0.06%)

5:33:16 PM EDT: $18.34 +0.27 (+1.50%)

Market Cap (Intraday)	869.82M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$34.66 Million
Adjusted EPS	-$0.64

See more estimates

10-Day MA	$18.99
50-Day MA	$18.26
200-Day MA	$12.39

See more pivots

UroGen Pharma Ltd Stock, NASDAQ:URGN

400 Alexander Park Drive, 4th floor, Princeton, New Jersey 08540

Israel

Phone: +1.646.768.9780

Number of Employees: 235

http://www.urogen.com

Description

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.